Enhanced Venglustat Pharmaceutical Compositions and Manufacturing Processes

The present inventive concept relates to novel pharmaceutical compositions and manufacturing processes of venglustat, providing improved bioavailability, reduced dosing frequency, and enhanced patient compliance.

The original patent disclosed pharmaceutical compositions comprising venglustat, but it had limitations in terms of bioavailability and patient compliance. The present inventive concept addresses these limitations by introducing controlled release oral dosage forms, taste-masking agents, and wearable devices for monitoring patient compliance.

The inventive concept comprises five key aspects: (1) a controlled release oral dosage form using a pH-dependent coating and a matrix forming excipient, (2) a chewable tablet with a taste-masking agent, (3) a system for monitoring patient compliance using a wearable device, (4) a novel granulation step in the manufacturing process, and (5) a pharmaceutical composition with a bioavailability enhancer. These aspects work together to provide improved bioavailability, reduced dosing frequency, and enhanced patient compliance.

The present inventive concept introduces a novel combination of a pH-dependent coating and a matrix forming excipient, a wearable device for monitoring patient compliance, and a bioavailability enhancer, which are not disclosed in the original patent. These features provide a non-obvious solution to the limitations of the original patent.

Alternative embodiments of the inventive concept could include different types of controlled release mechanisms, such as osmotic pumps or diffusion-controlled systems. Additionally, the wearable device could be replaced with a mobile application or a web-based platform for monitoring patient compliance.

The inventive concept has potential commercial applications in the treatment of Fabry disease and other lysosomal storage disorders. The market for venglustat is expected to grow significantly in the coming years, and the present inventive concept could capture a significant share of this market.